AIZ vs EBS · P/E 15, rev $12.81B vs rev $1.04B
Assurant Inc (AIZ) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AIZ revenue for 2025-12-31 was $12.81B. Net income was $872.7M. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AIZ and EBS stock pages for the full models.
Not investment advice.